0000795266-21-000123.txt : 20211015 0000795266-21-000123.hdr.sgml : 20211015 20211015164120 ACCESSION NUMBER: 0000795266-21-000123 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211013 FILED AS OF DATE: 20211015 DATE AS OF CHANGE: 20211015 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gilligan Thomas W. CENTRAL INDEX KEY: 0001553750 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09195 FILM NUMBER: 211326441 MAIL ADDRESS: STREET 1: C/O KB HOME STREET 2: 10990 WILSHIRE BOULEVARD, 7TH FLOOR CITY: LOS ANGELES STATE: CA ZIP: 90024 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KB HOME CENTRAL INDEX KEY: 0000795266 STANDARD INDUSTRIAL CLASSIFICATION: OPERATIVE BUILDERS [1531] IRS NUMBER: 953666267 STATE OF INCORPORATION: DE FISCAL YEAR END: 1130 BUSINESS ADDRESS: STREET 1: 10990 WILSHIRE BLVD CITY: LOS ANGELES STATE: CA ZIP: 90024 BUSINESS PHONE: 3102314000 MAIL ADDRESS: STREET 1: 10990 WILSHIRE BLVD CITY: LOS ANGELES STATE: CA ZIP: 90024 FORMER COMPANY: FORMER CONFORMED NAME: KAUFMAN & BROAD HOME CORP DATE OF NAME CHANGE: 19920703 4 1 wf-form4_163433046775839.xml FORM 4 X0306 4 2021-10-13 0 0000795266 KB HOME KBH 0001553750 Gilligan Thomas W. C/O KB HOME 10990 WILSHIRE BOULEVARD, 7TH FLOOR LOS ANGELES CA 90024 1 0 0 0 Common Stock 2021-10-13 4 M 0 10491 9.89 A 70488 D Common Stock 2021-10-13 4 D 0 4136 39.13 D 66352 D Common Stock 2021-10-13 4 M 0 7241 20.70 A 73593 D Common Stock 2021-10-13 4 D 0 2855 39.13 D 70738 D Common Stock 2021-10-13 4 M 0 9157 17.60 A 79895 D Common Stock 2021-10-13 4 D 0 3610 39.13 D 76285 D Common Stock 2021-10-14 4 S 0 35222 40.49 D 41063 D Non-Qualified Stock Option (Right to Buy) 9.89 2021-10-13 4 M 0 10491 0 D 2013-07-18 2022-07-18 Common Stock 10491.0 0 D Non-Qualified Stock Option (Right to Buy) 20.7 2021-10-13 4 M 0 7241 0 D 2014-04-04 2023-04-04 Common Stock 7241.0 0 D Non-Qualified Stock Option (Right to Buy) 17.6 2021-10-13 4 M 0 9157 0 D 2015-04-03 2024-04-03 Common Stock 9157.0 0 D Based on the reporting person's election, the reporting person received shares of the issuer's common stock equal in value to the positive difference between each exercised stock option's exercise price and the closing price of the issuer's common stock on the date of exercise. Accordingly, each exercised stock option was settled in a manner similar to a stock appreciation right. No shares of the issuer's common stock were sold in these transactions. Tony Richelieu, Attorney-in-Fact for Thomas W. Gilligan 2021-10-15